Agios Pharmaceuticals | AGIO - Trade Debtors

Stock Price
26.74
Daily Change
0.17 0.64%
Monthly
-6.31%
Yearly
-20.08%
Q1 Forecast
26.59

Agios Pharmaceuticals reported $5.03M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Agios Pharmaceuticals USD 5.03M 43K Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Amgen USD 8.49B 211M Sep/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Astellas Pharma JPY 810.23B 75.43B Dec/2025
AstraZeneca USD 17.56B 1.32B Sep/2025
Bayer EUR 14.91B 2.73B Sep/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Exelixis USD 311.3M 17.42M Sep/2025
Gilead Sciences USD 5.1B 314M Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Incyte USD 895.89M 53M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 1.05B 589M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025